Literature DB >> 21106739

Recombinant infectious bursal disease virus carrying hepatitis C virus epitopes.

Chitra Upadhyay1, Arun Ammayappan, Deendayal Patel, Imre Kovesdi, Vikram N Vakharia.   

Abstract

The delivery of foreign epitopes by a replicating nonpathogenic avian infectious bursal disease virus (IBDV) was explored. The aim of the study was to identify regions in the IBDV genome that are amenable to the introduction of a sequence encoding a foreign peptide. By using a cDNA-based reverse genetics system, insertions or substitutions of sequences encoding epitope tags (FLAG, c-Myc, or hepatitis C virus epitopes) were engineered in the open reading frames of a nonstructural protein (VP5) and the capsid protein (VP2). Attempts were also made to generate recombinant IBDV that displayed foreign epitopes in the exposed loops (P(BC) and P(HI)) of the VP2 trimer. We successfully recovered recombinant IBDVs expressing c-Myc and two different virus-neutralizing epitopes of human hepatitis C virus (HCV) envelope glycoprotein E in the VP5 region. Western blot analyses with anti-c-Myc and anti-HCV antibodies provided positive identification of both the c-Myc and HCV epitopes that were fused to the N terminus of VP5. Genetic analysis showed that the recombinants carrying the c-Myc/HCV epitopes maintained the foreign gene sequences and were stable after several passages in Vero and 293T cells. This is the first report describing efficient expression of foreign peptides from a replication-competent IBDV and demonstrates the potential of this virus as a vector.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106739      PMCID: PMC3020510          DOI: 10.1128/JVI.01391-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2.

Authors:  Bruno Da Costa; Christophe Chevalier; Celine Henry; Jean-Claude Huet; Stéphanie Petit; Jean Lepault; Hein Boot; Bernard Delmas
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Intentional coinfection of patients with HCV infection using avian infection bursal disease virus.

Authors:  Tibor Bakács; Jitendra N Mehrishi
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

3.  A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus.

Authors:  C Birghan; E Mundt; A E Gorbalenya
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

4.  Replication of infectious bursal disease virus in continuous cell lines.

Authors:  D H Jackwood; Y M Saif; J H Hughes
Journal:  Avian Dis       Date:  1987 Apr-Jun       Impact factor: 1.577

5.  Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.

Authors:  Teshome Mebatsion; Marck J M Koolen; Leonie T C de Vaan; Niels de Haas; Marian Braber; Angela Römer-Oberdörfer; Paul van den Elzen; Pieter van der Marel
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.

Authors:  J R Castón; J L Martínez-Torrecuadrada; A Maraver; E Lombardo; J F Rodríguez; J I Casal; J L Carrascosa
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  VP1 of infectious bursal disease virus is an RNA-dependent RNA polymerase.

Authors:  Ursula I von Einem; Alexander E Gorbalenya; Horst Schirrmeier; Sven-Erik Behrens; Tobias Letzel; Egbert Mundt
Journal:  J Gen Virol       Date:  2004-08       Impact factor: 3.891

Review 8.  Potential use of poliovirus as a vector.

Authors:  M Girard; A Martin; S van der Werf
Journal:  Biologicals       Date:  1993-12       Impact factor: 1.856

9.  Mice as potential carriers of infectious bursal disease virus in chickens.

Authors:  Min Joon Park; Jeong Ho Park; Hyuk Moo Kwon
Journal:  Vet J       Date:  2009-01-18       Impact factor: 2.688

10.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

View more
  4 in total

1.  Critical role for voltage-dependent anion channel 2 in infectious bursal disease virus-induced apoptosis in host cells via interaction with VP5.

Authors:  Zhonghua Li; Yongqiang Wang; Yanfei Xue; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

2.  Critical roles of glucocorticoid-induced leucine zipper in infectious bursal disease virus (IBDV)-induced suppression of type I Interferon expression and enhancement of IBDV growth in host cells via interaction with VP4.

Authors:  Zhonghua Li; Yongqiang Wang; Xiang Li; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

3.  Birnaviridae Virus Factories Show Features of Liquid-Liquid Phase Separation and Are Distinct from Paracrystalline Arrays of Virions Observed by Electron Microscopy.

Authors:  Vishwanatha R A P Reddy; Elle A Campbell; Joanna Wells; Jennifer Simpson; Salik Nazki; Philippa C Hawes; Andrew J Broadbent
Journal:  J Virol       Date:  2022-02-09       Impact factor: 6.549

4.  Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs.

Authors:  Tibor Bakacs; Rifaat Safadi; Imre Kovesdi
Journal:  Hepatol Med Policy       Date:  2018-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.